Spots Global Cancer Trial Database for cushing disease

Every month we try and update this database with for cushing disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease	NCT03774446	Cushing Disease	Seliciclib	18 Years -	Cedars-Sinai Medical Center
Hair Cortisol and Cushing's Disease	NCT04201444	Cushing Disease	Patient group Remission contr... Bilateral surre...	18 Years -	University Hospital, Bordeaux
Collecting Information About Treatment Results for Patients With Cushing's Syndrome	NCT03364803	Cushing's Disea... Cushing Syndrom... Cushing Disease	Cushing's QoL (... Nottingham Heal... Hospital Anxiet... Perceived Stres... Barratt's Impul... Beck Depression... State-Trait Anx... State Food Crav... Trait Food Crav... Visual Analogue... Sensitivity to ...	14 Years -	Memorial Sloan Kettering Cancer Center
Discriminant Capacity and Thresholds of Salivary Cortisol in Chemiluminescence in the Diagnosis of Hypercorticisms	NCT03974789	Cushing Disease	Blood test 24-hour Urine t... Saliva swab Dexamethasone t...	18 Years -	Centre Hospitalier Universitaire de Nīmes
Safety and Efficacy of LCI699 in Cushing's Disease Patients	NCT01331239	Cushings Diseas... Cushing Disease	LCI699	18 Years - 75 Years	Novartis
Health Status of the Patients Followed for a Disease of Cushing in the Region Large-West of 1990 to 2015	NCT03297892	Cushing Disease		18 Years -	University Hospital, Brest
Safety and Efficacy of LCI699 in Cushing's Disease Patients	NCT01331239	Cushings Diseas... Cushing Disease	LCI699	18 Years - 75 Years	Novartis
Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease	NCT00171951	Cushing Disease	Pasireotide	18 Years -	Novartis
The Factors Associated With the Recurrence in Patients With Cushing Disease	NCT02233335	Cushing Disease		-	National Taiwan University Hospital
Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease	NCT05971758	Cushing Disease	Fimepinostat	18 Years -	University of California, Los Angeles
Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease	NCT01915303	Cushings Diseas...	Pasireotide wit...	18 Years -	Novartis
Discriminant Capacity and Thresholds of Salivary Cortisol in Chemiluminescence in the Diagnosis of Hypercorticisms	NCT03974789	Cushing Disease	Blood test 24-hour Urine t... Saliva swab Dexamethasone t...	18 Years -	Centre Hospitalier Universitaire de Nīmes
Safety and Efficacy of LCI699 in Cushing's Disease Patients	NCT01331239	Cushings Diseas... Cushing Disease	LCI699	18 Years - 75 Years	Novartis
The Factors Associated With the Recurrence in Patients With Cushing Disease	NCT02233335	Cushing Disease		-	National Taiwan University Hospital
Long-Term Follow-Up of Survivors of Pediatric Cushing Disease	NCT03831958	Cushing Disease		2 Years - 90 Years	National Institutes of Health Clinical Center (CC)
Cushing´s Disease Epidemiology in Sweden	NCT02350153	Cushing Disease		18 Years -	Vastra Gotaland Region
Hair Cortisol and Cushing's Disease	NCT04201444	Cushing Disease	Patient group Remission contr... Bilateral surre...	18 Years -	University Hospital, Bordeaux
Clinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid Disorders	NCT04374721	Cushing Syndrom... Adrenal Insuffi... Cushing Disease Addison Disease	circadian gene ...	18 Years - 80 Years	University of Roma La Sapienza
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease	NCT03774446	Cushing Disease	Seliciclib	18 Years -	Cedars-Sinai Medical Center
Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease	NCT05971758	Cushing Disease	Fimepinostat	18 Years -	University of California, Los Angeles
Health Status of the Patients Followed for a Disease of Cushing in the Region Large-West of 1990 to 2015	NCT03297892	Cushing Disease		18 Years -	University Hospital, Brest
Open-label Treatment in Cushing's Syndrome	NCT03621280	Cushing Syndrom... Cushing Disease	Levoketoconazol...	18 Years -	Cortendo AB
Collecting Information About Treatment Results for Patients With Cushing's Syndrome	NCT03364803	Cushing's Disea... Cushing Syndrom... Cushing Disease	Cushing's QoL (... Nottingham Heal... Hospital Anxiet... Perceived Stres... Barratt's Impul... Beck Depression... State-Trait Anx... State Food Crav... Trait Food Crav... Visual Analogue... Sensitivity to ...	14 Years -	Memorial Sloan Kettering Cancer Center
Open-label Treatment in Cushing's Syndrome	NCT03621280	Cushing Syndrom... Cushing Disease	Levoketoconazol...	18 Years -	Cortendo AB

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: